Diasome Pharmaceuticals, Inc. — Form D

Diasome Pharmaceuticals, Inc. of CLEVELAND, OH, a company, filed a Form D exempt-offering notice with the SEC on 2022-09-08. The offering totals $19.1M, of which $16.7M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (23)

NameRoleLocation
Robert GehoPromoterCleveland, OH
Devang KantesariaDirectorMiami, FL
Marc PennDirectorCleveland, OH
Peter Blair TollmanDirectorCleveland, OH
Robert GehoDirectorCleveland, OH
Robert GehoExecutive OfficerCleveland, OH
Frank Blair McCaneyDirectorCleveland, OH
W. Blair GehoDirectorCleveland, OH
W. Blair GehoExecutive OfficerCleveland, OH
Thomas Blair McDonaldDirectorCleveland, OH
Cosme Blair OrdonezDirectorCleveland, OH
Thomas McDonaldDirectorMiami, FL
Marc Blair PennDirectorCleveland, OH
Frank McCaneyDirectorPhiladelphia, PA
W. Blair GehoDirectorCleveland, OH
Michele Blair OllierDirectorCleveland, OH
Helga Blair KautskyExecutive OfficerCleveland, OH
Guiseppe Blair ZoccoDirectorCleveland, OH
Richard Blair CarusoDirectorCleveland, OH
Len RosenbergDirectorConshohocken, PA
Len RosenbergExecutive OfficerConshohocken, PA
Richard CarusoDirectorVillanova, PA
Brenda GavinDirectorPhiladelphia, PA

Other filings by this issuer (7)

FiledFormOfferingSold
2024-08-15D$15.6M$3.1M
2023-06-30D$15.0M$9.0M
2020-12-23D$5.0M$1.5M
2020-04-01D$2.9M$2.9M
2018-10-26D$18.6M$12.1M
2017-01-17D$8.0M$4.3M
2009-04-13D/A$13.4M$12.9M

More